Mar 5 |
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
|
Mar 1 |
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
|
Mar 1 |
Tarsus Pharmaceuticals stock dips after pricing $100M securities offering
|
Mar 1 |
Tarsus Announces Pricing of $100.0 Million Public Offering
|
Feb 29 |
Tarsus announces proposed $100M public offering
|
Feb 29 |
Tarsus Pharmaceuticals files for automatic mixed securities shelf
|
Feb 29 |
Tarsus Announces Proposed $100.0 Million Public Offering
|
Feb 29 |
Party Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Earnings Forecasts
|
Feb 28 |
Here's Why Tarsus Pharmaceuticals, Inc. (TARS) is a Great Momentum Stock to Buy
|
Feb 28 |
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript
|